Get the Stockscreener App
44.03
4.83%
2.03
After Hours:
44.03
Praxis Precision Medicines Inc stock is traded at $44.03, with a volume of 463.73K.
It is up +4.83% in the last 24 hours and down -6.48% over the past month.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
See More
Previous Close:
$42.00
Open:
$42.18
24h Volume:
463.73K
Relative Volume:
1.09
Market Cap:
$926.81M
Revenue:
$1.77M
Net Income/Loss:
$-123.74M
P/E Ratio:
-4.8015
EPS:
-9.17
Net Cash Flow:
$-95.21M
1W Performance:
+9.45%
1M Performance:
-6.48%
6M Performance:
+13.10%
1Y Performance:
-23.72%
1-Day Range:
$41.89
$46.05
1-Week Range:
$37.24
$46.05
52-Week Range:
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Name
Praxis Precision Medicines Inc
Sector
Industry
Phone
617-300-8460
Address
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
44.03 | 884.08M | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-03-25 | Reiterated | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Aug-05-24 | Initiated | Oppenheimer | Outperform |
| Jun-24-24 | Initiated | Needham | Buy |
| Jun-18-24 | Initiated | Guggenheim | Buy |
| May-01-24 | Initiated | Robert W. Baird | Outperform |
| Sep-19-23 | Initiated | Truist | Buy |
| Jun-06-22 | Downgrade | Wedbush | Outperform → Neutral |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Aug-26-21 | Initiated | BofA Securities | Buy |
| Apr-26-21 | Initiated | William Blair | Outperform |
| Nov-11-20 | Initiated | Wedbush | Outperform |
| Nov-10-20 | Initiated | Cowen | Outperform |
| Nov-10-20 | Initiated | Evercore ISI | Outperform |
| Nov-10-20 | Initiated | Piper Sandler | Overweight |
View All
Praxis Precision Medicines Inc Stock (PRAX) Latest News
Woodline Partners LP Has $6.66 Million Stake in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Will Alpha Cognition Inc. face regulatory challengesBuy Signal & Free Real-Time Volume Trigger Notifications - خودرو بانک
Investment Report: Can Praxis Precision Medicines Inc. be recession proofJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - خودرو بانک
Praxis Precision Medicines stock maintains Overweight rating at Piper Sandler - Investing.com
Will Praxis Precision Medicines Inc. stock recover after recent dropJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Can Praxis Precision Medicines Inc. be recession proofBuy Signal & Comprehensive Market Scan Reports - خودرو بانک
Growth Recap: Is Praxis Precision Medicines Inc forming bullish engulfing patternsInflation Watch & Safe Entry Momentum Tips - خودرو بانک
Aug Closing: Will Praxis Precision Medicines Inc benefit from current market trendsJuly 2025 Highlights & High Accuracy Buy Signal Tips - خودرو بانک
Aug Sectors: Is Praxis Precision Medicines Inc.’s ROIC above industry average2025 Dividend Review & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Panic Selling: Is Praxis Precision Medicines Inc currently under institutional pressureJuly 2025 Reactions & Scalable Portfolio Growth Methods - خودرو بانک
Goldman Sachs Group Inc. Sells 102,131 Shares of Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Investor Mood: Is Praxis Precision Medicines Inc. forming a breakout patternJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Buybacks Report: What is the Moat Score of Live Oak Acquisition Corp Equity WarrantM&A Rumor & AI Enhanced Trading Alerts - خودرو بانک
Bull Run: Will Group 1 Automotive Inc. benefit from geopolitical trendsOptions Play & Momentum Based Trading Signals - خودرو بانک
Aug Patterns: Is Praxis Precision Medicines Inc stock a smart retirement pickJuly 2025 Price Swings & Verified Momentum Stock Ideas - خودرو بانک
Aug Final Week: Is ClearSign Technologies Corporation attractive for institutional investorsJuly 2025 Recap & Daily Oversold Bounce Ideas - خودرو بانک
How does Praxis Precision Medicines Inc. score in quality rankingsJuly 2025 Selloffs & Weekly Market Pulse Updates - خودرو بانک
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Praxis Precision Medicines, Inc. on Behalf of Praxis Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 5.9%Time to Sell? - MarketBeat
Using data filters to optimize entry into Praxis Precision Medicines Inc.Buy Signal & Daily Chart Pattern Signals - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc.PRAX - cnhinews.com
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap DownWhat's Next? - MarketBeat
Invesco Ltd. Has $442,000 Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Alyeska Investment Group L.P. Cuts Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Equities Analysts Offer Predictions for PRAX Q3 Earnings - MarketBeat
Praxis Precision Medicines, Inc. $PRAX Stake Boosted by Cormorant Asset Management LP - MarketBeat
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat
Praxis Precision Medicines Signs New Sales Agreement - MSN
14,762 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by Nuveen LLC - MarketBeat
Ally Bridge Group NY LLC Has $3.62 Million Stock Holdings in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Published on: 2025-09-08 21:26:00 - beatles.ru
Real Time Data Flags Unusual Activity in Praxis Precision Medicines Inc.Portfolio Gains Summary & Smart Investment Allocation Insights - beatles.ru
Should you wait for a breakout in Praxis Precision Medicines Inc.Market Performance Summary & Verified Technical Signals - Newser
What makes Praxis Precision Medicines Inc. stock price move sharplyJuly 2025 Retail & Daily Oversold Bounce Ideas - Newser
What earnings revisions data tells us about Praxis Precision Medicines Inc.2025 Sector Review & Low Risk High Reward Ideas - Newser
Will Praxis Precision Medicines Inc. benefit from macro trendsJuly 2025 Trends & High Conviction Trade Alerts - Newser
How to use a screener to detect Praxis Precision Medicines Inc. breakouts2025 Market Trends & High Accuracy Buy Signal Tips - Newser
Analyzing drawdowns of Praxis Precision Medicines Inc. with statistical tools2025 Volatility Report & Technical Entry and Exit Tips - Newser
Is Praxis Precision Medicines Inc. trending in predictive chart modelsPortfolio Return Summary & Fast Gain Stock Trading Tips - Newser
Using R and stats models for Praxis Precision Medicines Inc. forecastingDollar Strength & Growth Oriented Trade Recommendations - Newser
Risk adjusted return profile for Praxis Precision Medicines Inc. analyzedAnalyst Downgrade & Accurate Buy Signal Alerts - Newser
Will Praxis Precision Medicines Inc. outperform during market ralliesForecast Cut & Low Risk High Reward Ideas - خودرو بانک
Why is Praxis Precision Medicines Inc. stock going downJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Invesco Ltd. Sells 75,305 Shares of Praxis Precision Medicines, Inc. $PRAX - Defense World
Analysts Set Expectations for PRAX Q3 Earnings - Defense World
Praxis Precision Medicines ends ATM agreement with Jefferies, initiates new $250 million program with TD Cowen - Investing.com South Africa
Strategic Shift in Capital Raising: Praxis Precision Medicines' Transition from Jefferies to TD Securities - AInvest
Praxis Precision Medicines Terminates 2024 Sales Agreement With JefferiesSEC Filing - TradingView
Praxis Precision Medicines terminates 2024 sales agreement with JefferiesSEC filing - MarketScreener
Praxis Precision Medicines Inc Stock (PRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):